Published in Acta Pharm Suec on January 01, 1977
Pharmacokinetics and metabolism of delta 1-tetrahydrocannabinol and other cannabinoids with emphasis on man. Pharmacol Rev (1986) 1.61
Plasma delta-9 tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking. Clin Pharmacol Ther (1980) 1.43
The combination of gas chromatography and mass spectrometry in the identification of drugs and metabolites. Adv Pharmacol Chemother (1969) 1.29
Do plasma concentrations of delta 9-tetrahydrocannabinol reflect the degree of intoxication? J Clin Pharmacol (1982) 0.95
Clinical effects and plasma levels of delta 9-tetrahydrocannabinol (delta 9-THC) in heavy and light users of cannabis. Psychopharmacology (Berl) (1981) 0.93
Single-dose kinetics of deuterium-labelled cannabidiol in man after smoking and intravenous administration. Biomed Environ Mass Spectrom (1986) 0.92
Fate and metabolism of some hallucinogenic indolealkylamines. Adv Pharmacol (1968) 0.91
Interactions of delta 1-tetrahydrocannabinol with cannabinol and cannabidiol following oral administration in man. Assay of cannabinol and cannabidiol by mass fragmentography. Experientia (1981) 0.90
Pharmacokinetics of clomethiazole in healthy adults. Acta Pharmacol Toxicol (Copenh) (1978) 0.90
Plasma kinetics of methaqualone in man after single oral doses. Eur J Clin Pharmacol (1973) 0.89
Alkaloids in certain species of Virola and other South American plants of ethnopharmacologic interest. Acta Chem Scand (1969) 0.87
Single dose kinetics of deuterium labelled delta 1-tetrahydrocannabinol in heavy and light cannabis users. Biomed Mass Spectrom (1982) 0.86
Metabolism of 5-methoxy-N,-N dimethyltryptamine- 14 C in the rat. Biochem Pharmacol (1969) 0.86
(+)-4-Dimethylamino-2,alpha-dimethylphenethylamine (FLA 336(+)), a selective inhibitor of the A form of monoamine oxidase in the rat brain. Biochem Pharmacol (1982) 0.85
Cocaine in blood of coca chewers. J Ethnopharmacol (1979) 0.85
Bioavailability of D-propoxyphene, acetyl salicylic acid, and phenazone in a combination tablet (Doleron): interindividual variation and influence of food intake. Acta Med Scand (1977) 0.82
Plasma levels of delta 9-tetrahydrocannabinol after intravenous, oral, and smoke administration. NIDA Res Monogr (1981) 0.82
Plasma concentrations and effects of methaqualone after single and multiple oral doses in man. Eur J Clin Pharmacol (1974) 0.81
Identification of in vitro metabolites of delta 1-tetrahydrocannabinol formed by human livers. Drug Metab Dispos (1982) 0.80
Metabolism of pentachlorophenol. Arch Toxicol (1974) 0.80
Alkaloid content of Banisteriopsis rusbyana. Am J Pharm Sci Support Public Health (1969) 0.79
Quantitation of 1-tetrahydrocannabinol in plasma from cannabis smokers. J Pharm Pharmacol (1973) 0.78
Pressor response of oral tyramine in healthy men given amiflamine and placebo. Clin Pharmacol Ther (1986) 0.78
Relationship between brain levels of 3-(3-hydroxyphenyl)-N-n-propylpiperidine HCl enantiomers and effects on locomotor activity in rats. J Pharmacol Exp Ther (1992) 0.77
Peyote alkaloids: identification in a prehistoric specimen of lophophora from coahuila, Mexico. Science (1978) 0.77
Neutral in vivo metabolites of cannabinol isolated from rat faeces. J Pharm Pharmacol (1977) 0.76
Identification of two new beta-carboline alkaloids in South American hallucinogenic plants. Biochem Pharmacol (1968) 0.76
Single-dose kinetics of deuterium-labelled cannabinol in man after intravenous administration and smoking. Biomed Environ Mass Spectrom (1987) 0.76
Biliary excretion of delta1-tetrahydrocannabinol and its metabolites in the rat. Biochem Pharmacol (1974) 0.76
Natural occurrence of 4-dimethylallyltryptophan-an ergot alkloid precursor. Tetrahedron Lett (1968) 0.76
Chemical synthesis and biological occurrence of carboxylic acid metabolites of delta1(6)-tetrahydrocannabinol. Drug Metab Dispos (1979) 0.76
Behavioural and biochemical effects of subchronic treatment with raclopride in the rat: tolerance and brain monoamine receptor sensitivity. Pharmacol Toxicol (1991) 0.75
In vivo metabolites of cannabinol identified as fatty acid conjugates. J Pharm Pharmacol (1978) 0.75
Introduction to quantification of cannabinoids and their metabolites in biological fluids. Adv Biosci (1980) 0.75
Cactaceae alkaloids. XXIII. Alkaloids of Pachycereus pecten-aboriginum and Cereus jamacaru. Lloydia (1976) 0.75
Biotransformation and elimination of ketocaine in rats. Acta Pharm Suec (1977) 0.75
Quantification of delta 1-tetrahydrocannabinol in tissues and body fluids. Arch Toxicol Suppl (1983) 0.75
[Identification of potential cannalis containing substance metabolites: nuclear resonance and mass spectroscopic studies on side chain hydroxylation of cannabinoids]. Helv Chim Acta (1974) 0.75
Plasma and cerebrospinal fluid concentrations of pentazocine in patients: assay by mass fragmentography. J Pharm Pharmacol (1974) 0.75
Systemic absorption of ketocaine following epicutaneous administration. Acta Pharm Suec (1981) 0.75
Monohydroxylated metabolites of delta-1-tetrahydrocannabinol in mouse brain. Comparison with in vitro liver metabolites. Acta Pharm Suec (1974) 0.75
Analysis of "morphine base". Arch Toxikol (1973) 0.75
Guide to the analysis of cocaine and its metabolites in biological material. J Ethnopharmacol (1981) 0.75
Simultaneous GLC determination of zimelidine and norzimelidine. Synthesis of secondary amines as closely related internal standards. Acta Pharm Suec (1979) 0.75
Quantitative determination of 5-hydroxyindole-3-acetic acid in cerebrospinal fluid by gas chromatography-mass spectrometry. Anal Chem (1972) 0.75
Identification of monohydroxylated metabolites of cannabidiol formed by rat liver. J Pharm Pharmacol (1976) 0.75
In vivo neutral metabolites of cannabinol from rat faeces [proceedings]. West Afr J Pharmacol Drug Res (1977) 0.75
Dioxygenated metabolites of cannabidiol formed by rat liver. J Pharm Pharmacol (1976) 0.75
Mass spectrometry of methaqualone metabolites. Fragmentation patterns of the monohydroxy derivatives. Acta Pharm Suec (1972) 0.75
Elimination of N-(2-aminoacyl)-2,6-xylidines after intravenous infusion in dogs. Acta Pharm Suec (1977) 0.75
Correlations between in vitro dissolution rate and bioavailability of alaproclate tablets. J Pharmacokinet Biopharm (1984) 0.75
The combination of gas chromatography and mass spectrometry in the identification of drugs and metabolites. Adv Pharmacol (1969) 0.75
Detection and quantification of tetrahydrocannabinol in blood plasma. NIDA Res Monogr (1976) 0.75
The chemical identity of "hog"--a "new" hallucinogen. Am J Pharm Sci Support Public Health (1969) 0.75
Guide to the analysis of phencyclidine and its metabolites in biological material. Arch Toxicol Suppl (1983) 0.75
Acidic metabolites of delta1-tetrahydrocannabinol isolated from rabbit urine. J Pharm Pharmacol (1979) 0.75
Tolerance and pilot pharmacokinetics of amiflamine after increasing single oral doses in healthy subjects. Clin Pharmacol Ther (1986) 0.75
Metabolism of 7-hydroxy- 1(6)-tetrahydrocannabinol in the rabbit. Acta Pharm Suec (1973) 0.75
Splanchnic elimination and systemic toxicity of bupivacaine and etidocaine in man. Acta Anaesthesiol Scand (1977) 0.75
Maternal and foetal drug levels after epicutaneous application of a local anaesthetic formulation containing ketocaine for possible use as pain relief in labour. Acta Anaesthesiol Scand (1981) 0.75
Effect on platelet behaviour of beta-benzal-butyric acid. Acta Med Scand Suppl (1971) 0.75
Mass fragmentographic identification of O-Methylcorpalline in Pilosocereus guerreronis. Lloydia (1977) 0.75
[Hepatic coma: 2 cases of experimental treatment with temporary heterotopic graft]. Acta Chir Belg (1972) 0.75
[Methaqualone--story about a sleeping medicine]. Lakartidningen (1974) 0.75
A method for the identification of acid metabolites of tetrahydrocannabinol (THC) by mass fragmentography. NIDA Res Monogr (1976) 0.75